Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p/DDX5 axis

Artificial Cells, Nanomedicine, and Biotechnology
Xinxin ChenXiao Wang

Abstract

Long non-coding RNAs (LncRNAs) have been proven to be involved in the progression of osteosarcoma. LncRNA DLEU1 was found to act as an oncogene in various types of cancer. In this study, we aimed to explore the biological functions of DLEU1 in osteosarcoma and the specific mechanism. Our results showed that DLEU1 was highly expressed in osteosarcoma tissue specimens and cells. Downregulation of DLEU1 in osteosarcoma cells inhibited the cell proliferation, migration and invasion. Further mechanistic analysis and functional assays demonstrated that DLEU1 exerted its role by sponging microRNA (miR)-671-5p in osteosarcoma cells. Moreover, DEAD-box helicase 5 (DDX5) was confirmed as the target of miR-671-5p. Furthermore, rescue assays indicated that miR-671-5p inhibitor significantly reversed the effects of DLEU1 knockdown on osteosarcoma cell proliferation and invasion while restoration of DDX5 rescued the proliferation and invasion of osteosarcoma cells transfected with miR-671-5p mimics. In conclusion, DLEU1 acted as an oncogene in osteosarcoma by directly sponging miR-671-5p and regulating the expression of DDX5. These findings suggested that DLEU1 might be a novel therapeutic target in the treatment of osteosarcoma.

References

Aug 1, 1997·Pediatric Clinics of North America·P A Meyers, R Gorlick
Feb 4, 2009·Nature Reviews. Genetics·Tim R MercerJohn S Mattick
Feb 26, 2009·Cell·Chris P PontingWolf Reik
Sep 20, 2011·Molecular Cell·Kevin C Wang, Howard Y Chang
Mar 8, 2013·Biochemical and Biophysical Research Communications·Jin-Ping LiTao Xiao
Mar 26, 2013·Biochimica Et Biophysica Acta·Frances V Fuller-Pace
Jan 1, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zheng LiJianxiong Shen
Feb 18, 2016·Genomics, Proteomics & Bioinformatics·Yiwen Fang, Melissa J Fullwood
Jan 20, 2017·Oncotarget·Ruiling ChenZhengdong Cai
Nov 13, 2018·Biochimica Et Biophysica Acta. Reviews on Cancer·Rose Magoma NyamaoFeng-Min Zhang
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Song ZhangQigang Zhang

❮ Previous
Next ❯

Citations

Mar 3, 2020·Journal of Biochemical and Molecular Toxicology·Cao MaYao Kong
Jan 24, 2020·Current Pharmaceutical Design·Chaoying SongChengfu Yuan
Jan 8, 2021·International Journal of General Medicine·Lili WangYongning Sun
Nov 12, 2020·Frontiers in Genetics·Qian ChenBingqing Qiu
May 8, 2021·Cancer Management and Research·Hong ZengRu Feng
Nov 6, 2021·Journal of Gastrointestinal Cancer·Roghieh GhodratiBehzad Baradaran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.